Drugs / Novex
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04146103 | Apr 2018 → Jan 2019 | benign prostatic hyperplasia | Saint-Joseph University | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Novex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04146103 ↗ |
| Route | Oral | “The compound will be administered orally two tablets daily for 3 months.” NCT04146103 ↗ |